Phone: 86-17339854922
Mail: sales20@interlgroup.com
Add: Room 305 , 3/F , Haipai Decoration Office Building , Yudu Avenue , Yuncheng , Shanxi
Obeticholic Acid powder Raw Materials CAS 459789-99-2
Product Overview:
Obeticholic Acid powder, also known as 6-ethyl channedeoxycholic acid, is a novel derivative of channedeoxycholic acid (CDCA) in human primary bile acids. Obeticholic acid powder is a natural ligand of farnesate derivative X receptor (FXR). Obeticholic Acid is a farnesol X receptor agonist. Obeticholic acid indirectly inhibits cytochrome 7A1 (CYP7A1) gene expression by activating farnesol X receptor. Since CYP7A1 is a rate-limiting enzyme for cholic Acid biosynthesis, Obeticholic Acid can inhibit cholic acid synthesis for the treatment of primary biliary cirrhosis and non-alcoholic fatty liver disease.
Obeticholic Acid powder Raw Materials CAS 459789-99-2 Attributes
MF:C26H44O4
MW:420.63
EINECS:810-245-2
Specification:Obeticholic Acid powder
Sample:Obeticholic Acid powder
Brand:Obeticholic Acid powder
Appearance: powder
Storage: Cool Dry Place
Brand: chemical Raw Materials
Shelf Life: 2 Years
Test Method: HPLC
Obeticholic Acid powder Raw Materials CAS 459789-99-2 Details
Uses and synthesis of Obeticholic Acid powder
Obeticholic Acid powder, also known as 6-ethyl channedeoxycholic acid, is a novel derivative of channedeoxycholic acid (CDCA) in human primary bile acids. Obeticholic acid powder is a natural ligand of farnesate derivative X receptor (FXR). Obeticholic Acid is a farnesol X receptor agonist. Obeticholic acid indirectly inhibits cytochrome 7A1 (CYP7A1) gene expression by activating farnesol X receptor. Since CYP7A1 is a rate-limiting enzyme for cholic Acid biosynthesis, Obeticholic Acid can inhibit cholic acid synthesis for the treatment of primary biliary cirrhosis and non-alcoholic fatty liver disease.
Applications/Functions of Obeticholic Acid powder
- Obeticholic Acid powder (OCA) is a potent agonist of synthetic modified bile acids and farnesoid X nuclear receptor (FXR) for the treatment of liver diseases, including primary cholangitis.
- Since CYP7A1 is a rate-limiting enzyme for cholic Acid biosynthesis, Obeticholic Acid can inhibit cholic acid synthesis for the treatment of primary biliary cirrhosis and non-alcoholic fatty liver disease.
Physicochemical Property of Obeticholic Acid powder